Kinga Tobola-Wrobel

Dr. Kinga Tobola-Wrobel

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
KTKinga Tobola-Wrobel
Kinga Tobola-Wrobel
MPMarek Pietryga
Marek Pietryga
PDPiotr Dydowicz
Piotr Dydowicz
MSMarta Szukalska
Marta Szukalska
JBJacek Brązert
Jacek Brązert
EFEwa Florek
Ewa Florek
The pathophysiological mechanism underlying pregnancy complications such as congenital malformations, miscarriage, preeclampsia, or fetal growth restriction is not entirely known. However, the negative impact of the mother’s body oxidative imbalance on the fetus and the course of gestation is increasingly discussed. This article is an integrative review of some original studies and review papers on the effects of oxidative stress on the adverse pregnancy outcomes mainly birth defects in fetuses. A systematic search for English language articles published from 2010 until 2020 was made, using MEDLINE data. Additionally, we analyzed the Cochrane and Scopus databases, discussions with experts, and a review of bibliography of articles from scientifically relevant and valuable sources. The main purposes are to assess the contribution of the existing literature of associations of oxidative stress on the etiology of the abovementioned conditions and to identify relevant information and outline existing knowledge. Furthermore, the authors aim to find any gaps in the research, thereby providing grounds for our own research. The key search terms were “oxidative stress in pregnancy,” “oxidative stress and congenital malformations,” and “oxidative stress and adverse pregnancy outcomes.” Studies have confirmed that oxidative stress has a significant impact on pregnancy and is involved in the pathomechanism of adverse pregnancy outcomes.

1 July 2017 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
MPMarek Pietryga
Marek Pietryga
PDPiotr Dydowicz
Piotr Dydowicz
KTKinga Tobola-Wrobel
Kinga Tobola-Wrobel
MSMarta Szukalska
Marta Szukalska
IMIzabela Miechowicz
Izabela Miechowicz
EFEwa Florek
Ewa Florek

23 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KZKatarzyna Ziółkowska
Katarzyna Ziółkowska
KTKinga Tobola-Wrobel
Kinga Tobola-Wrobel
MPMarek Pietryga
Marek Pietryga
GKGrażyna Kasprzak
Grażyna Kasprzak
AJAleksander Jamsheer
Aleksander Jamsheer
EWEwa Wysocka
Ewa Wysocka
Are the maternal gene variants MTHFR: c.665C>T, MTHFR: c.1286A>C, MTR: c.2756A>G, MTRR: c.66A>G, RFC1: c.80C>T and TCN2: c.776G>C and blood markers of the folate pathway important factors in assessing the risk of fetal trisomy 21 (fetal-T21)? Twenty pregnant women with a high risk and twenty with a low risk of fetal-T21 underwent prenatal examination. Selected gene variants and folate pathway markers and pregnancy-associated plasma protein A (PAPP-A) and free β-subunit of human chorionic gonadotropin β (free-β-hCG) multiple of the medians (MoMs) were determined. The distributions of the alternative alleles and genotypes of the gene variants did not differ between the studied groups. There was no relationship between PAPP-A and β-hCG MoM values and the presence of allele alternative genotype variants. The occurrence of alternative variants of the selected genes and concentrations of most of the studied folate pathway markers may not play a crucial role in the risk of fetal-T21 in pregnant women. However, the relationships between erythrocyte folate concentrations and the occurrence of alternative variants: c.665C>T MTHFR and c.776G>C TCN2, as well as the methylmalonic acid concentration and the occurrence of alternative variant c.776G>C TCN2 in pregnant women with fetal-T21, encourage further research. So far, of the biochemical markers, maternal PAPP-A and β-hCG MoM values remain independent risk factors for fetal-T21.

11 March 2026 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
AGAleksandra Gladych-Macioszek
Aleksandra Gladych-Macioszek
UMUrszula Mantaj
Urszula Mantaj
KTKinga Tobola-Wrobel
Kinga Tobola-Wrobel
SRSandra Radzicka-Mularczyk
Sandra Radzicka-Mularczyk
RSRafal Sibiak
Rafal Sibiak
EWEwa Wender-Ozegowska
Ewa Wender-Ozegowska
The rise in type 2 diabetes (T2D) during pregnancy is mainly due to increasing obesity and metabolic disorders. Early gestational diabetes mellitus (eGDM),